John Hausdorff, MD
Hospice and Palliative Medicine · Monterey, CANPI 1972540516
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $64 of the $87 with a category attached, or 72.9%. E.r. Squibb & Sons, L.L.C. accounts for 78.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hospice and palliative medicine clinicians in CA, where the typical reported total is $105.
Across 3 payments — averaging $29.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$69
- Daiichi Sankyo Inc.$19
Across 25 payments — averaging $2719.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$39K
- E.r. Squibb & Sons, L.L.C.$29K
What the payments were for
- Food & beverage$6473%
- Education$2427%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 2 | $69 |
| Daiichi Sankyo Inc. | 1 | $19 |
How this compares
$87 in reported general payments places this provider in the 40th percentile of 195 hospice and palliative medicine providers in California.
See all hospice and palliative medicine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 20 | $65,580 |
| OxycontinOxycodone Hcl | 13 | $17,311 |
| Nucynta ErTapentadol Hcl | 12 | $16,713 |
| XareltoRivaroxaban | 12 | $14,686 |
| EliquisApixaban | 13 | $7,578 |
| Morphine Sulfate | 24 | $2,415 |
| Oxycodone Hcl | 19 | $935 |
| Amiodarone Hcl | 21 | $826 |
| Quetiapine Fumarate | 35 | $801 |
| Fentanyl | 12 | $751 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $654 |
| Methenamine Hippurate | 13 | $577 |
| Prednisone | 64 | $547 |
| Nebivolol Hcl | 14 | $539 |
| Levothyroxine Sodium | 39 | $538 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Monterey
- Sharon YeeArcadia$44K
- Neil SoniFountain Valley$28K
- Marietta Abalos-GalitoSan Jose$21K
- Humayon KhanSanta Ana$7K
- Sorin BugaDuarte$5K
- Glenn CarrFresno$5K
- Steven HarrisFoster City$5K
- Christopher PhillipsMurrieta$4K
- William DaleDuarte$3K
- Nehal PatelLaguna Hills$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.